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The aim of this study was to see how nifedipine counters the effects of cocaine on hepatic and brain 
enzymatic activity in rats and whether it affects urinary excretion of cocaine. Male Wistar rats were divided 
in four groups of six: control, nifedipine group (5 mg kg-1 i.p. a day for fi ve days); cocaine group (15 mg 
kg-1 i.p. a day for fi ve days), and the nifedipine+cocaine group. Twenty-four hours after the last 
administration, we measured neuronal nitric oxide synthase (nNOS) activity in the brain and cytochrome 
P450 quantity, ethylmorphine-N-demethylase, and anilinehydroxylase activity in the liver. Urine samples 
were collected 24 h after the last cocaine and cocaine+nifedipine administration. Urinary cocaine 
concentration was determined using the GC/MS method.
Cocaine administration increased brain nNOS activity by 55 % (p<0.05) in respect to control, which 
indicates the development of tolerance and dependence. In the combination group, nifedipine decreased 
the nNOS activity in respect to the cocaine-only group.
In the liver, cocaine signifi cantly decreased and nifedipine signifi cantly increased cytochrome P450, 
ethylmorphine-N-demethylase, and anilinehydroxylase in respect to control. In combination, nifedipine 
successfully countered cocaine effects on these enzymes.
Urine cocaine excretion in the cocaine+nifedipine group signifi cantly dropped (by 35 %) compared to the 
cocaine-only group.
Our results have confi rmed the effects of nifedipine against cocaine tolerance and development of 
dependence, most likely due to metabolic interactions between them.
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Multiple cocaine administration leads to 
behavioural activation, tolerance, and development of 
dependence in animals and humans (2). These adaptive 
changes in the central nervous system (CNS) are 
largely mediated by L-type calcium channels (3). One 
of the mechanisms underlying drug tolerance and 
dependence, and the related withdrawal syndrome, is 
a change in calcium homeostasis and the consequent 
activation of N-methyl-D-aspartate/nitric oxide 
(NMDA/NO) cascade (4). Changes in Ca2+ homeostasis 
seem to be induced by calcium channel blockers of 
the 1,4-dihydropyridine type.
In our earlier studies (5-6), we have demonstrated 
that nifedipine, co-administered with morphine, 
attenuates withdrawal symptoms, which correlate with 
changes in the activity of neuronal nitric oxide 
synthase (nNOS) (5). Interactions between morphine 
and nifedipine in the liver and on the level of urine 
excretion were also observed, probably due to a 
metabolic interaction between these compounds (6).
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Nifedipine is known to induce one of the most 
abundant cytochrome P450 isoform CYP 3A and other 
isoenzymes, including CYP 2B (7). In rats, these two 
enzymes mediate partial N-demethylation of cocaine 
to norcocaine (8). Data on cocaine effects on drug-
metabolising enzymes are controversial (9-11). In our 
earlier studies, we investigated the effect of cocaine 
on brain and liver cytochrome P450 after multiple 
administration in rats and found that the cumulative 
intraperitoneal (i.p.) dose of 15 mg kg-1 led to a 
signifi cant increase in the quantity of cytochrome P450 
(12) and in ethylmorphine-N-demethylase (CYP 3A) 
(13) and anilinehydroxylase (CYP 2E1) activity (14). 
These fi ndings suggest that cocaine and nifedipine 
interact in the brain and liver. The aim of this study 
was to see to which extent and also to see if nifedipine 
affects urinary excretion of cocaine in Wistar rats.
MATERIAL AND METHODS
Animals
To avoid the infl uence of hormonal fl uctuations 
during the oestrus cycle, this study included only male 
Wistar rats (b. w. 200 g to 230 g). Many have observed 
sex-related differences in the behavioural response to 
and toxicity of cocaine (15, 16).
The animals were housed in рlexiglass cages (three 
per cage) at (20±2) °C and 12 h light/dark cycles. Food 
and tap water were provided ad libitum. The animals 
were purchased from the National Breeding Centre, 
Slivnitza, Bulgaria. All experiments were performed 
after at least one week of adaptation to this environment. 
All procedures were approved by the Institutional 
Animal Care Committee and observed the principles 
of the European Convention for the Protection of 
Vertebrate Animals used for Experimental and Other 
Scientifi c Purposes (ETS 123) (17).
Experimental design
The animals were randomised into four groups of 
six. The fi rst group received i.p. doses of 5 mg kg-1 
nifedipine once daily for fi ve days (18). The second 
group received 15 mg kg-1 of cocaine i.p. once daily 
for fi ve days (19). The third group received nifedipine 
(5 mg kg-1) followed by cocaine (15 mg kg-1) 30 min 
later. This combination was also administered once 
daily for fi ve days. The selection of nifedipine and 
cocaine doses was based on our earlier study (12) and 
on doses commonly used by other laboratories (18, 
19). Our earlier study (12) demonstrated that 5 mg kg-
1 of nifedipine, administered intraperitoneally to male 
Wistar rats once daily for fi ve days, led to increases 
in cytochrome P450. The fourth group consisted of 
control animals, which were treated with saline, 
involved in the experiment from the very beginning, 
and housed under the same standard laboratory 
conditions as the treated animals.
Twenty-four hour urine was collected from animals 
from the second and third group, which were 
transferred to stainless steel metabolism cages 40 min 
after the last injection of cocaine and/or nifedipine.
Twenty-four hours after the last injection, all 
animals were killed by decapitation, brain and liver 
removed, washed with ice-cold saline (0.9 % NaCl), 
blotted dry, weighed, and stored on ice. Liver was then 
divided into three pieces of one gram each to determine 
cytochrome P450, glutathione (GSH), and enzyme 
activity.
Chemicals and reagents
All reagents used were of analytical grade. Cocaine 
hydrochloride, nifedipine hydrochloride, sucrose, Tris, 
DL-dithiotreitol, phenylmethylsulfonyl fluoride, 
potassium phosphate, calcium chloratum (CaCl2), 
magnesium chloratum (MgCl2), L-arginine, L-valine, 
haemoglobin bovine, beta-Nicotinamide adenine 
dinucleotide 2’-phosphate reduced tetrasodium salt 
(beta-NADPH), ethylenediaminetetraacetic acid 
(EDTA), and bovine serum albumin (fraction V) were 
purchased from Sigma Chemical Co. (Taufkirchen, 
Germany). 2,2’-dinitro-5,5’dithiodibenzoic acid 
(DTNB) was obtained from Merck (Darmstadt, 
Germany).
Preparation of brain tissue extracts and assessment 
of nNOS activity
Rats were decapitated and the brains minced and 
homogenised in 9 mL of a buffer containing 
320 mmol L-1 sucrose, 50 mmol L-1 Tris, 1 mmol L-1 
DL-dithiotreitol, 100 μg L-1 phenylmethylsulfonyl 
fl uoride (pH=7.2), according to the method used by 
Knowels and Moncada (20). The homogenates were 
then centrifuged at 17,000 rpm for 60 min. Protein 
content was measured using the method of Lowry (21) 
with bovine serum albumin as a standard.
nNOS activity was measured spectrophotometrically, 
using the oxidation of oxyhaemoglobin to 
methaemoglobin by NO (20) with slight modifi cations. 
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The incubation medium contained 40 mmol L-1 
potassium phosphate buffer, pH=7.2, 200 μmol L-1 
CaCl2, 1 mmol L
-1 MgCl2, 100 μmol L
-1 L-arginine, 
50 mmol L-1 L-valine, 2.6 μmol L-1 oxyhaemoglobin, 
100 μmol L-1 NADPH, and brain extract. The 
concentration of oxyhaemoglobin in the original 
method of Knowels (20) was 1.6 μmol L-1, but we 
adjusted it to 2.6 μmol L-1 to optimise reproducibility 
and to obtain spectra with a higher amplitude.
Change in absorbance at 401 nm and 421 nm was 
monitored with a double split beam spectrophotometer 
(Spectro UV-VIS Split) at 37 °C. Enzyme activity was 
expressed in nmol mg-1 per minute, using a millimolar 
extinction coefficient for methaemoglobin 
77.2 L mol-1 cm-1.
Urine analysis
For urine collection, animals were housed for 24 h 
in metabolism cages, equipped to separate urine and 
faeces. Food and water were available ad libitum.
A 1.0-mL aliquot of urine was mixed with 
NaHCO3:K2CO3 (1:2), рН=9.6 by shaking manually 
in 20 mL glass tubes. Then we added Na2SO4 
anhydrous and 20 μL codeine as internal standard. 
Samples were extracted with 4 mL of tert-
butylmethylether for 30 min and then centrifuged at 
2,500 rpm for 5 min. To separate the organic from 
non-organic phase, the samples were put in cryostat 
at -29 °C. The separated ether phase was then 
evaporated to dryness under a stream of nitrogen.
The purifi ed dried extract was added to 50 μL N-
Methyl-N-trimethylsilyltrifl uoroacetamide (MBTFA) 
and derivatised at 80 °C for 20 min. Aliquots of 1 μL 
were injected into a gas chromatograph/mass 
spectrometer (GC-MS, Agilent Technology, Santa 
Clara, USA) to determine cocaine concentrations.
Preparations of standard and internal control
Stock solution of cocaine was prepared in methanol 
to yield a fi nal drug concentration of 10 μg L-1. The 
standard curve for cocaine was linear over the 
concentration range of 0.1 μg L-1 to 0.4 μg L-1. 
Linearity was verifi ed by adding (10, 20, 30, and 
40) μL from the stock solution to drug-free urine. The 
concentration of the working solution of the internal 
standard, codeine, was 21.8 μg L-1.
Preparation of liver microsomes for biochemical 
assay
The excised liver was perfused with 0.15 mol L-1 
KCl, minced, and homogenised with 3 mL of 1.17 % 
KCl solution in a glass homogenizer (PX-OX 2000) 
as described by Guengerich (22). Liver homogenates 
were then centrifuged at 9,000 rpm for 30 min. 
Supernatant fractions were further centrifuged at 
38,000 rpm for 60 min. The resulting microsomal 
pellets were stored at -20 °C until assayed.
Ethylmorphine-N-demethylase activity was 
evaluated based on the measurement of formaldehyde, 
trapped in the solution as semicarbazone, using the 
colorimetric procedure of Nash (23), at 415 nm.
Aniline hydroxylase activity was evaluated 
colorimetrically, based on the measurement at 630 nm 
of a phenol-indophenol complex, which is a converted 
form of 4-aminophenol (24).
To quantify cytochrome P450 we resuspended the 
microsomal pellets and diluted them in phosphate 
buffer + 1 mmol L-1 EDTA (pH=7.4) (25). The protein 
content of liver homogenate was measured using the 
method of Lowry (17) with bovine serum albumin as 
a standard. Cytochrome P450 quantity was quantifi ed 
spectrophotometrically as a complex with CO at 
450 nm and expressed as nmol mg-1.
To assess GSH levels, samples of liver tissue were 
homogenised in 5 % trichloracetic acid (TCA) and 
centrifuged at 4,000 rpm for 20 minutes. GSH was 
assessed by measuring non-protein sulfhydryls after 
precipitation of proteins with TCA, followed by 
measurement of thiols in the supernatant by the DTNB 
reagent using the method described by Bump et al. 
(26).
Statistical analysis
Statistical analysis included ANOVA and Student’s 
t-test. Probability values of less than 0.05 were 
considered signifi cant. The results were presented as 
means ± SD of six animals per group. For each 
parameter three parallel samples were tested.
RESULTS
Table 1 shows the effects of cocaine and nifedipine 
on nNOS activity in rat brain. Compared to control, 
cocaine administered alone increased nNOS activity 
by 55 % (p<0.05) while nifedipine alone did not 
signifi cantly change its activity. In combination with 
cocaine, however, nifedipine decreased nNOS activity 
by 27 % (p<0.05) in respect to cocaine alone.
Table 2 shows the effects of cocaine and nifedipine, 
administered alone and in combination, on liver 
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enzymes and P450. Nifedipine given alone showed 
the opposite effects to cocaine, signifi cantly increasing 
cytochrome P450 quantity (28 %) and ethylmorphine-
N-demethylase (34 %) and anilinehydroxylase (27 %) 
activity in respect to control. These results are in good 
correlation with our earlier fi ndings (5, 12).
Cocaine signifi cantly depleted GSH (by 29 %; 
p<0.05 in respect to control), while nifedipine did not 
change its levels. However, in the cocaine+nifedipine 
group GSH level increased 20 % in respect to the 
cocaine-only group (p<0.05).
In combination, nifedipine signifi cantly increased 
cytochrome P450 (by 34 %), ethylmorphine-N-
demethylase (101 %) and anilinehydroxylase (41 %) 
activities, and increases GSH levels (20 %) in relation 
to the cocaine only group. Compared to control, GSH 
levels dropped 15 % (p<0.05).
Table 3 shows the effects of nifedipine on urinary 
excretion of cocaine. In the nifedipine+cocaine group, 
cocaine excretion dropped 35 % (p<0.05) in comparison 
with the cocaine-only group.
DISCUSSION
The signifi cant increase in nNOS activity observed 
after fi ve days of cocaine administration in our study 
confirms earlier findings (19, 27) and could be 
regarded as a sign of tolerance and development of 
dependence.
Table 1  nNOS activity in rat brain after multiple administration of cocaine (15 mg kg-1 per day) and nifedipine (5 mg kg-1 per 
day), alone and in combination
Group nNOS activity / nmol min
-1 
mg-1 of tissue Effect vs. control / % Effect vs. cocaine / %
Control 0.604±0.04 100
Nifedipine 0.597±0.08 98.9
Cocaine 0.935±0.012* 155 100
Nifedipine + Cocaine 0.683±0.10+ 113 73
Note: Data are expressed as mean±SD of six animals
* p<0.05 vs. control group
+ p< 0.05 vs. cocaine treated group
Table 2  Multiple administration of cocaine (15 mg kg-1 per day), alone and along with nifedipine (5 mg kg-1 per day) – effect 
on liver biochemical parameters
Group Cytochrome P450# / nmol mg-1
Ethylmorphine-
N-demethylase activity 
as HCHO / nmol min-1 mg-1 
of tissue
Anilinehydroxylase 
activity / nmol min-1 
mg-1 of tissue
Quantity of GSH / 
nmol g-1
Control 0.345±0.02 0.258±0.02 0.037±0.002 5.31±0.20
Nifedipine 0.440±0.04* 0.346±0.02* 0.047±0.003* 5.18±0.13
Cocaine 0.286±0.01* 0.165±0.04* 0.031±0.003* 3.77±0.11*
Cocaine + 
Nifedipine
0.384±0.05+ 0.332±0.01*+ 0.044±0.005*+ 4.54±0.41*+
Note: Data are expressed as mean±SD of six animals
* p<0.05 vs. control group
+ p< 0.05 vs. cocaine treated group
# - previously published in (12)
Table 3  Urinary excretion of cocaine (15 mg kg-1 per day) after multiple administrations alone and in combination with nifedipine 
(5 mg kg-1 per day)





Cocaine 0.57±0.02 6±1 -
Cocaine + Nifedipine 0.37±0.09* 6.5±1.5 ↓35
Note: data are expressed as mean±SD of six animals
* p<0.05 vs. cocaine treated group
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Vetulani (28) has proposed that L-type Ca2+ channel 
blockers like 1,4-dihydropiridines could be used as 
anti-addiction agents. Our results showed that 
nifedipine countered cocaine effects on nNOS activity 
when given in combination with it. This is in agreement 
with a study by Nasif et al. (29), who found that 
repeated cocaine administration stimulated voltage-
sensitive Ca2+ channel function in rat mPFC pyramidal 
neurons as a result of the increased activity of L-type 
Ca2+ channels. The authors also showed that selective 
blocking of L-type Ca2+ channels by nifedipine not 
only signifi cantly increased the threshold but also 
reduced the duration and amplitude of Ca2+ plateau 
potentials that resulted in a decrease of Ca2+ infl ux into 
the neurons.
Apart from this interaction on the level of the CNS, 
cocaine and nifedipine are also expected to interact in 
the liver, since both undergo hepatic biotransformation. 
Nifedipine is a substrate of CYP 3A and other 
isoenzymes such as CYP 2B (30, 31) which mediate 
cocaine’s N-demethylation to N-hydroxynorcocaine 
in liver microsomes (32-34). Our results seem to 
confi rm this interaction, since nifedipine successfully 
counteracted cocaine effects when administered in 
combination.
This includes lowering cocaine-induced toxic 
effects in the liver. According to Yu et al. (35), cocaine 
is oxidised by cytochrome P450 to N-hydroxynorcocaine 
and norcocaine nitroxyde. The latter is a free radical 
that induces lipid peroxidation and GSH depletion. In 
our study, we detected a signifi cant decrease in GSH 
levels after cocaine administration. Co-administration 
with nifedipine, however, resulted in increased GSH 
levels (Table 2). Similarly, Mazumder et al. (36) 
suggested that nifedipine attenuated lipid peroxidation 
and glutathione depletion caused by sulphur 
mustard.
In order to confi rm this metabolic interaction, we 
also investigated the effects of nifedipine on the 
urinary excretion of cocaine. In a study by Nayak et 
al. (38), urinary excretion of unchanged cocaine in 
chronically treated rats was around 1.5 % (37). In our 
study, we measured unchanged urinary cocaine 
because we expected it to increase due to nifedipine 
interference with its cytochrome P450-mediated 
metabolism. However, our results proved us wrong, 
as urinary cocaine excretion in the combination group 
was signifi cantly lower than in the cocaine-only group 
(Table 3). These fi ndings suggest that the observed 
metabolic interaction between cocaine and nifedipine 
might result in an increased activity of non-microsomal 
enzymes, which may explain the decreased urinary 
excretion of unchanged cocaine.
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Sažetak
NIFEDIPIN UBLAŽAVA DJELOVANJE KOKAINA NA ENZIMSKU AKTIVNOST U MOZGU I JETRI 
TE SMANJUJE NJEGOVO IZLUČIVANJE PUTEM MOKRAĆE
Cilj je ovoga istraživanja bio utvrditi kako nifedipin ublažava djelovanje kokaina na enzimsku aktivnost 
u mozgu i jetri Wistar štakora te utječe li na njegovo izlučivanje putem mokraće. Mužjaci su podijeljeni 
u četiri skupine po šest jedinki: kontrolnu skupinu, nifedipinsku skupinu koja je pet dana intraperitonealno 
primala nifedipin u dozi od 5 mg kg-1; skupinu koja je pet dana primala kokain u dozi od 15 mg kg-1 na 
dan te skupinu koja je zajedno primala nifedipin i kokain u odgovarajućim dozama.
Dvadeset i četiri sata nakon posljednje doze izmjerena je enzimska aktivnost sintaze dušičnoga oksida 
(nNOS) u mozgu, razina citokroma P450 te aktivnosti enzima etilmorfi n-N-demetilaze i anilinhidroksilaze 
u jetri štakora.
Uzorci mokraće prikupljeni su 24 sata nakon posljednje doze kokaina odnosno kombinacije nifedipina i 
kokaina. Koncentracija kokaina u mokraći izmjerena je s pomoću vezanog sustava plinske kromatografi je 
i spektrometrije masa.
Kokain je povećao aktivnost nNOS-a u mozgu za 55 % (p<0,05) u odnosu na kontrolnu skupinu, što 
upućuje na stvaranje tolerancije i ovisnosti. U kombiniranoj skupini nifedipin je značajno smanjio aktivnost 
nNOS-a u odnosu na skupinu koja je primila samo kokain.
Kokain je značajno snizio, a nifedipin značajno povisio razinu citokroma P450 u jetri te aktivnost etilmorfi n-
N-demetilaze i anilinhidroksilaze u odnosu na kontrolnu skupinu. U kombiniranoj skupini nifedipin je 
uspješno ublažio djelovanje kokaina na aktivnost spomenutih enzima.
Izlučivanje kokaina putem mokraće u kombiniranoj skupini bilo je značajno manje (35 %) nego u skupini 
koja je primala samo kokain.
Ovi rezultati potvrđuju da nifedipin štiti od djelovanja kokaina i stvaranja ovisnosti, najvjerojatnije zbog 
interakcija u metabolizmu dvaju spojeva.
KLJUČNE RIJEČI: anilinhidroksilaza, citokrom P450, etilmorfi n-N-demetilaza, GSH, nNOS
CORRESPONDING AUTHOR:
Vessela Vitcheva
 Department of Pharmacology, Pharmacotherapy 
and Toxicology
Faculty of Pharmacy, Medical University Sofi a
Dunav str. 2, 1000 Sofi a, Bulgaria
E-mail: vesselavitcheva@yahoo.com
Vitcheva V, et al. INFLUENCE OF NIFEDIPINE ON COCAINE TOXICITY
Arh Hig Rada Toksikol 2011;62:131-137
